Altuviiio May See Rapid Uptake Upon European Approval In Hemophilia A

Pediatric Data Clears Path For EMA Filing

 
• By Alaric DeArment
  
Sanofi announced results of the Phase III XTEND-Kids study of Factor VIII replacement therapy Altuviiio • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D